MIRA INFORM REPORT

 

IDENTIFICATION DETAILS

 

Name :

SHELL LIFESCIENCES PRIVATE LIMITED

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMS65353B

 

 

PAN No.:

[Permanent Account No.]

AALCS1719E

 

 

Legal Form :

Private Limited Liability Company

 

 

No. of Employees :

13 (Approximately)

 

 

BUSINESS DETAILS

 

Line of Business :

Trading of Pharma Chemicals.

 

 

Imports :

 

Products :

Bulk Drugs

Countries :

China

 

 

Terms :

 

Selling :

Credit (45 / 90 Days)

 

 

Purchasing :

L/C (90 Days), Credit, DP and DA

 

 

GENERAL INFORMATION

 

Suppliers :

Bajaj Health Care Limited

 

 

Customers :

Manufacturers

 

·         Zoitas

·         Virbac

 

 

No. of Employees :

13 (Approximately)

 

 

Bankers :

Bank of Baroda, C. P. Tank Branch, Halai Lohana Mahajan Building, 6/10, Babasaheb Jaykar Marg, Mumbai - 400002, Maharashtra, India

 

 

Facilities :

Letter of Credit: Rs. 900.000 Millions (From Bank of Baroda)

Cash Credit: Rs. 10.000 Millions (From Bank of Baroda)

 

 

 

Banking Relations :

 

 

 

Auditors :

 

Name :

Manan H Karvat

Chartered Accountant

Address :

101, Kailash Darshan, New Link Road, Anand Nagar, Dahisar (East), Mumbai – 400068, Maharashtra, India

Income-tax PAN of auditor or auditor's firm :

AXRPK6011H

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 10.09.2012

 

Names of Shareholders

 

No. of Shares

 

Kiran Chandrakant Thakker

 

170000

Madhuben Chandrakant Thakker

 

80000

Total

 

250000

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

2.500

2.500

0.100

(b) Reserves & Surplus

4.582

3.547

0.812

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

7.082

6.047

0.912

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

3.301

9.054

4.917

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

2.952

5.402

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

6.253

14.456

4.917

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

9.055

6.181

0.000

(b) Trade payables

52.310

58.542

36.682

(c) Other current liabilities

2.532

0.780

0.156

(d) Short-term provisions

0.610

0.510

0.250

Total Current Liabilities (4)

64.507

66.013

37.088

 

 

 

 

TOTAL

77.842

86.516

42.917

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

0.087

2.183

0.000

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

1.951

0.000

0.000

(c) Deferred tax assets (net)

0.025

0.031

0.000

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

2.063

2.214

0.000

 

 

 

 

(2) Current assets

 

 

 

(a) Current investmentss

0.000

0.000

0.000

(b) Inventories

10.462

7.791

10.319

(c) Trade receivables

49.333

66.523

29.603

(d) Cash and cash equivalents

4.368

0.634

1.802

(e) Short-term loans and advances

11.616

9.354

1.177

(f) Other current assets

0.000

0.000

0.016

Total Current Assets

75.779

84.302

42.917

 

 

 

 

TOTAL

77.842

86.516

42.917

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

 

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

232.295

197.537

89.340

 

 

Other Income

0.067

0.021

0.117

 

 

TOTAL                                     (A)

232.362

197.558

89.457

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Purchase of Stock In Trade

225.724

184.908

93.593

 

 

Change in Inventory of FG, WIP and Stock-in-trade

(2.671)

2.528

(9.874)

 

 

Employee Benefit Expenses

3.418

3.176

2.115

 

 

Other Expenses

2.219

4.096

2.814

 

 

Prior Period Expenses

0.137

0.000

0.000

 

 

TOTAL                                     (B)

228.827

194.708

88.648

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

3.535

 

2.850

0.809

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

1.850

0.866

0.000

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

1.685

1.984

0.809

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

0.035

0.328

0.000

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)                 (G)           

1.650

1.656

0.809

 

 

 

 

 

Less

TAX                                                                  (H)

0.615

0.480

0.249

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX (G-H)                  (I)

1.035

1.176

0.560

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

4.14

4.71

56.00

 

Particulars

 

 

 

31.03.2014

 

 

 

 

Sales Turnover (Approximately)

 

 

300.000

 

 

 

 

 

The above information has been parted by Mr. Kiran Chandrakant Thakker (Director).

 

 

CORPORATE INFORMATION

 

Subject is a private limited company domiciled in India, incorporated under the Companies Act, 1956. The company is a Trading of Pharma Chemicals.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (30)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

RBI DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

LOCATIONS

 

Registered Office :

Unit No. 1413/1414, 14th Floor, Ghanshyam Enclave, Linking Road, Kandivali (West), Mumbai – 400067, Maharashtra, India

Tel. No. :

91-22-28672582

Mobile No. :

91-9820429344 (Mr. Kiran Chandrakant Thakker)

Fax No. :

Not Available

E-Mail :

kiranthakkar08@hotmail.com

kiran@shelllifesciences.com

Area :

950 sq.ft.

Location :

Owned

 

 

Warehouse :

H. No. 263/26, Gala No. 9, 1st Floor, Manish Compound, Building No. 2, Rehnal Village, Anjur Phata, Bhiwandi, Thane, Maharashtra, India

Area :

400 sq.ft.

Location :

Rented

 

 

CHANGE OF ADDRESS

 

The registered office of the company has been shifted from Shop No.18, Ground Floor, Shree Krishna CHS Limited, Mahavir Nagar, Kandivali (West), Mumbai – 400067, Maharashtra, India to the present address w.e.f. 13.06.2013.

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.